Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease.
about
RNA interference-based nanosystems for inflammatory bowel disease therapyRecent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel diseaseNew strategies for treatment of inflammatory bowel diseaseOral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy.Urocanic acid-modified chitosan nanoparticles can confer anti-inflammatory effect by delivering CD98 siRNA to macrophagesPlant derived edible nanoparticles as a new therapeutic approach against diseases.Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapyCombination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.Glycoprotein CD98 as a receptor for colitis-targeted delivery of nanoparticle.Therapeutic gene delivery using bioreducible polymers.Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging.pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms.Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice.Targeted Metagenome Based Analyses Show Gut Microbial Diversity of Inflammatory Bowel Disease patients.Oral delivery of curcumin via porous polymeric nanoparticles for effective ulcerative colitis therapy.Nanotherapeutics for the treatment of inflammatory bowel disease.Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
P2860
Q28071518-70FA5A62-8E5A-4C7C-BBB1-D1DFA09669F3Q28073219-F7B027D6-4A5A-4DDD-A5AC-5213007A50B1Q35069777-2E3419FE-622F-4612-A155-C60E1B681280Q36414624-8CA08944-10A4-41A6-BEE4-DEFBC1EEF3E5Q36869459-7FD37199-3C5A-40C0-85CE-756AFC66C90EQ37012929-2044014B-338F-4777-81A4-6B26D770CB8FQ37146028-CBA5ECF2-60FB-4B7B-8C38-2AE1B403702CQ37469872-98B75330-5B17-4795-A499-9E801595C489Q37695146-3226B8F0-FF82-48EB-B742-80ADF4AC1CA6Q38157750-5ED2B4A1-2A35-449C-9C1F-AC5917D69143Q38425098-01EEB5F9-FF94-4439-9FAA-36C40BA1B510Q38757836-C84EC546-40AC-4527-87A0-C431640F7D4DQ38834450-1113ADF7-9BEB-413E-8495-759203D1DAD6Q40047810-40C1A4A3-0D61-4641-A12A-C2B0AC1654C6Q46272530-89FF8F10-7FCD-4036-A969-C0713167F852Q47941914-FB3DAE52-E941-4899-8AB8-EF9941E824ADQ47980720-05824471-D5FA-49C3-8765-A5721FEB7333
P2860
Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Oral colon-specific therapeuti ...... of inflammatory bowel disease.
@en
type
label
Oral colon-specific therapeuti ...... of inflammatory bowel disease.
@en
prefLabel
Oral colon-specific therapeuti ...... of inflammatory bowel disease.
@en
P2860
P1476
Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease
@en
P2093
Didier Merlin
P2860
P304
P356
10.1517/17425247.2012.730517
P407
P50
P577
2012-10-05T00:00:00Z